Page last updated: 2024-11-03

prazosin and Disorders of Sex Development

prazosin has been researched along with Disorders of Sex Development in 1 studies

Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.

Disorders of Sex Development: In gonochoristic organisms, congenital conditions in which development of chromosomal, gonadal, or anatomical sex is atypical. Effects from exposure to abnormal levels of GONADAL HORMONES in the maternal environment, or disruption of the function of those hormones by ENDOCRINE DISRUPTORS are included.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goepel, M1
Krege, S1
Price, DT1
Michelotti, GA1
Schwinn, DA1
Michel, MC1

Other Studies

1 other study available for prazosin and Disorders of Sex Development

ArticleYear
Characterization of alpha-adrenoceptor subtypes in the corpus cavernosum of patients undergoing sex change surgery.
    The Journal of urology, 1999, Volume: 162, Issue:5

    Topics: Adrenergic alpha-Antagonists; Binding, Competitive; Disorders of Sex Development; Dose-Response Rela

1999